Zuclopenthixol
Sponsors
Universitair Medisch Centrum Utrecht, Les Hopitaux Universitaires De Strasbourg, Birte Glenthoj, Technical University of Munich, Hannover Medical School
Conditions
Anxiety DisordersDementiaDepressionPatient with a diagnosis of schizophrenia spectrum disorder (SSD): schizophreniaPsychosomatic DisordersSchizoaffective DisordersSchizophreniaSchizophrenia and Disorders With Psychotic Features
Phase 3
Pharmacovigilance in Gerontopsychiatric Patients
TerminatedNCT02374567
Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28
A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatment) in patients with schizophrenia spectrum disorder after Stratification based on patients’ psychotic PHENotype: a personalized medicine approach
Not yet recruitingCTIS2023-509558-80-00
Target: 288Updated: 2025-07-17
Phase 4
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
CompletedNCT02307396
Start: 2015-02-01End: 2016-06-22Updated: 2018-10-11
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.
RecruitingCTIS2023-506602-39-00
Start: 2024-08-01Target: 310Updated: 2025-03-04